SCHEMBL1940756

SCHEMBL1940756

CSc1nn2c(I)cccc2c1NC(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 3/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
KHK P50053 3/20 0.31
HTR6 P50406 4/20 0.31
MEN1 O00255 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MAPT P10636 2/20 0.31
GRM5 P41594 1/20 0.30
TAS1R3 Q7RTX0 1/20 0.30
TAS1R1 Q7RTX1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27228493 0.84 MAPT (0.34) LMNASMN1; SMN2ALDH1A1RXFP1L3MBTL1
SCHEMBL4033910 0.66 GAA (0.36) LMNASMN1; SMN2CYP3A4CYP2D6CYP2C9
SCHEMBL27228405 0.64 HTR1A (0.41) LMNASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL4333871 0.59 POLB (0.60) LMNAALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL25296196 0.57 LMNA (0.34) LMNA
SCHEMBL2183784 0.56 RECQL (0.61) LMNASMN1; SMN2ALDH1A1TSHRHSD17B10
SCHEMBL25045802 0.56 DRD2 (0.40) CYP1A2
SCHEMBL22979601 0.55 LMNA (0.43) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2
SCHEMBL26121151 0.55 CA1 (0.48) LMNASMN1; SMN2ALDH1A1TSHRHSD17B10
SCHEMBL5361399 0.55 CA12 (0.47) SMN1; SMN2TSHRHSD17B10KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389618-B1 PYRAZOLO 1,5-A PYRIDINES AND MEDICINES CONTAINING THE SAME EISAI R&D MAN CO LTD (JP) 2011-06-15 EP disclosed
US-7625925-B2 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD (JP) 2009-12-01 US disclosed
EP-1555265-B1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS EISAI R&D MAN CO LTD (JP) 2009-03-25 EP disclosed
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS HIBI SHIGEKI 2008-03-27 US disclosed
US-7323569-B2 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-29 US disclosed
US-20070249663-A1 PYRAZOLO[1,5-a]PYRIDINES AND MEDICINES CONTAINING THE SAME HIBI SHIGEKI 2007-10-25 US disclosed
US-7285666-B2 Pyrazolo[1,5-a] pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-10-23 US disclosed
US-7176216-B2 7-phenylpyrazolopyridine compounds EISAI CO., LTD. (JP) 2007-02-13 US disclosed
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds EISAI CO.LTD. (JP) 2006-10-19 US disclosed
US-20060217348-A1 Pyrazolo[1,5-a] pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-09-28 US disclosed
US-7091215-B2 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI CO., LTD. (JP) 2006-08-15 US disclosed
EP-1555265-A1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS Eisai Co., Ltd. (JP) 2005-07-20 EP disclosed
US-20040224974-A1 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-11-11 US disclosed
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-06-24 US disclosed
EP-1389618-A1 PYRAZOLO 1,5-A]PYRIDINES AND MEDICINES CONTAINING THE SAME Eisai Co., Ltd. (JP) 2004-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249663-A1 PYRAZOLO[1,5-a]PYRIDINES AND MEDICINES CONTAINING THE SAME NR3C1, NR3C2, NR5A2 LMNA 2983/4885SMN1; SMN2 3648/4885ALDH1A1 2022/4885
US-20040224974-A1 7-phenylpyrazolopyridine compounds CRHR1, MC2R, CRH LMNA 4734/4885SMN1; SMN2 4074/4885ALDH1A1 2616/4885
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS MC2R, CRHR1, CRHR2 LMNA 4727/4885SMN1; SMN2 3905/4885ALDH1A1 3348/4885
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same XDH, NR3C1, NR5A1 LMNA 2972/4885SMN1; SMN2 3499/4885ALDH1A1 1142/4885
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds MC2R, CRHR1, CRHR2 LMNA 4718/4885SMN1; SMN2 4045/4885ALDH1A1 3334/4885
US-20060217348-A1 Pyrazolo[1,5-a] pyridines and medicines containing the same NR3C1, NR3C2, NR5A2 LMNA 2983/4885SMN1; SMN2 3648/4885ALDH1A1 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.